We are seeking an outstanding scientist with experience in a range of biophysical techniques to join Curve Therapeutics, an innovative, venture-backed start-up company based in Southampton, UK. The successful applicant will become part of a multidisciplinary team that is discovering and developing innovative therapeutics for the treatment of cancer. The candidate will be employed as […]
Curve Therapeutics is a venture-backed start-up company based on an innovative approach to targeting challenging disease targets developed by Prof Ali Tavassoli. The platform has been used to identify and report a number of cell-active, first in class inhibitors (including Miranda et al., 2013, J. Am. Chem. Soc. 135, 10418, Leitch et al., 2018, Chem. […]
Our CSO, Prof Ali Tavassoli, discusses his career, academic research and experience with building a Biotech company with Tom Froggatt in the “Careers in Drug Discovery” podcast. Listen to Ali and Tom’s conversation on iTunes or Spotify.
Southampton, UK, 31st July 2019. Curve Therapeutics (Curve) a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, today announces its participation in the UK BioIndustry Association’s 2021 Parliament Day. This annual event gives senior representatives from the UK biotech sector the opportunity to meet with MPs, Ministers and Peers to discuss key […]
Southampton, UK, 31st March 2021. Curve Therapeutics (Curve) a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, today announces the grant of US Patent 10,962,549 describing novel Microcycles that inhibit both HIF-1 and HIF-2. Curve originated from world-leading Microcycle® research conducted by Professor Tavassoli’s group in the Department of Chemistry at the […]
Southampton, UK, 31st July 2020. Curve Therapeutics (Curve) a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, today announces an investment of £2.25 Mn from Epidarex Capital, a trans-Atlantic venture capital firm that invests in early-stage, high growth life science and health technology companies in emerging and under-ventured research hubs within the […]
